James Wooldridge - Mar 4, 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Chief Medical Officer
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Stock symbol
CMPI
Transactions as of
Mar 4, 2021
Transactions value $
$0
Form type
4
Date filed
4/28/2022, 05:03 PM
Next filing
Aug 6, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +54.6K $0.00 54.6K Mar 4, 2021 Common Stock 54.6K $13.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 25% on the first anniversary of the vesting start date of March 5, 2021 and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Persons continued service through such date.